Short Communication
Comparison of Drug and Non-Drug Treatment Options of Fibromyalgia
Abdul Kader Mohiu*
Department of Pharmacy, World University of Bangladesh, Bangladesh
Abdul Kader Mohiuddin, Department of Pharmacy, World University of Bangladesh, Bangladesh.
Received Date: August 05, 2019; Published Date: August 22, 2019
Abstract
There is no clear specific pathophysiological therapeutic target of fibromyalgia (FM) management. The management of this complex condition has thus perplexed the medical community for many years, and several national and international guidelines have aimed to address this complexity. Pain relieving pharmaceutical medications are generally connected with an assortment of unfriendly reactions, for example, constipation, urinary retention, nausea, sedation, respiratory depression, myoclonus, delirium, sexual dysfunction, and hyperalgesia. The challenge of achieving adequate pain control without adverse side effects further compounds the problem and provides rationale for seeking complementary medicine and nonmedicine alternatives.
Keywords: Fibromyalgia; Chronic noncancer pain; Neurofeedback; Cognitive behavioral therapy; Acceptance and commitment therapy; Inflammatory arthritis
Abbreviations: FM: Fibromyalgia; RA: Rheumatoid Arthritis; NSAIDs: Non-Steroidal Anti-Inflammatory Drugs; CNCP: Chronic Noncancer Pain; PEA: Palmitoylethanolamide; FODMAP: Fermentable Oligo-, Di-, Mono-saccharides And Polyols; EMG-BFB: Electroencephalography Biofeedback; CBT: Cognitive Behavioral Therapy; IL-6: Interleukin-6, TNF-α: Tumor Necrosis Factor Alpha; ACT: Acceptance And Commitment Therapy; HRQoL: Health-Related Quality of Life; WBV: Whole Body Vibration; EA: Electro-acupuncture; HBOT: Hyperbaric Oxygen Therapy; LLLT: Low-Level Laser Therapy; TENS: Transcutaneous Electrical Nerve Stimulation
-
Abdul Kader Mohiuddin. Comparison of Drug and Non-Drug Treatment Options of Fibromyalgia Glob J Ortho Res. 1(5): 2019. GJOR. MS.ID.000522.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.